VERUS CAPITAL PARTNERS, LLC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1796874
SCOTTSDALE, AZ
Position in AQST
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$158,496
-$55,747 QoQ
Shares Held
38,100
-26.2% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 185 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VERUS CAPITAL PARTNERS, LLC holds $242,296 across 2 Drug Manufacturers - Specialty & Generic names. AQST ranks #1 (65.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AQST |
Aquestive Therapeutics, Inc.
This page
|
38,100 | $158,496 | |
| 2 | EBS |
Emergent BioSolutions Inc.
|
10,000 | $83,800 |
All Filings in AQST
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $158,496 | 38,100 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $214,243 | 51,625 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $392,768 | 60,800 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $187,824 | 33,600 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||